Trials / Completed
CompletedNCT01316016
Antidiabetic Properties of Rose Hip
Effects of Rose Hip Intake on Risk Markers of Type 2 Diabetes and Cardiovascular Disease: a Randomized Double-blind Cross-over Investigation in Obese Persons
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Lund University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether daily intake of a drink containing rose hip powder reduces risk markers of type diabetes and cardiovascular disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Rose hip | 40 g of rose hip powder daily for 6 weeks. |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-02-01
- Completion
- 2011-01-01
- First posted
- 2011-03-16
- Last updated
- 2011-03-16
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01316016. Inclusion in this directory is not an endorsement.